logo
Select company
Select metric
67.93%Debt to Assets Ratio
VS
Market
9
Sector
9
Industry
9
History
-
$ 2.52Close
$ 2.36 - $ 27 52-Week Range
Ticker Information

Ticker

AIM

Company Name

AIM IMMUNOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

AIM IMMUNOTECH INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AIM - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 4.13M$ 2.81M67.93%
3/31/2025$ 6.25M$ 2.52M40.36%
12/31/2024$ 8.61M$ 2.94M34.17%
9/30/2024$ 13.59M$ 3.4M25.03%
6/30/2024$ 15.71M$ 3.36M21.37%
3/31/2024$ 16.19M$ 3.35M20.69%
12/31/2023$ 19.38M$ 718K3.7%
9/30/2023$ 27.86M$ 750K2.69%
6/30/2023$ 33.62M$ 803K2.39%
3/31/2023$ 37.46M$ 814K2.17%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AIM IMMUNOTECH INC's latest trailing twelve months (TTM) Debt to Assets stands at 3.66%.
  • Over the past 5 years, AIM IMMUNOTECH INC's average Debt to Assets has been 11.87%.
  • The median Debt to Assets for AIM IMMUNOTECH INC during this period was 2.84%
  • AIM IMMUNOTECH INC reached its highest Debt to Assets over the past 5 years at 67.93%.
  • The lowest Debt to Assets recorded by AIM IMMUNOTECH INC in the same timeframe 0.23%

AIM IMMUNOTECH INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
SILO : SILO PHARMA INC 0%VIVS : VIVOSIM LABS INC 6.86%HCWB : HCW BIOLOGICS INC 23.48%CDIO : CARDIO DIAGNOSTICS HOLDINGS INC 5.99%IBO : IMPACT BIOMEDICAL INC 117.27%PMCB : PHARMACYTE BIOTECH INC 0%APVO : APTEVO THERAPEUTICS INC 26.94%ACXP : ACURX PHARMACEUTICALS INC 0%PALI : PALISADE BIO INC 5.07%GNPX : GENPREX INC 0%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for AIM IMMUNOTECH INC is calculated as follows: Debt [ $ 2.35M ] / Assets [ $ 64.16M ]
(=) Debt to Assets [ 3.66% ]

AIM - Debt to Assets Ratio, Last 5 years

0.23%

Minimum

Sep 30, 2021

67.93%

Maximum

Jun 30, 2025

11.87%

Average

2.84%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.33% with a standard deviation of 24.49%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.37K
min0%
max116.6%
average26.33%
median21.09%
std24.49%